Clinical Management of Patients with BRCA mutation
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In this segment, Dr. Critchfield looks at reasons why BRCA testing is so important in the physician's diagnostic repertoire, and the methods of helping patients reduce cancer risks after receiving a positive test. He then shares studies currently being undertaken to further evaluate the role of BRCA in prevention and treatment protocols. The interview concludes with a review of legislative efforts to regulate genetic testing, and Dr. Critchfield's personal outlook in projecting genetic testing's roles ten years into the future.
Overview
In this segment, Dr. Critchfield looks at reasons why BRCA testing is so important in the physician's diagnostic repertoire, and the methods of helping patients reduce cancer risks after receiving a positive test. He then shares studies currently being undertaken to further evaluate the role of BRCA in prevention and treatment protocols. The interview concludes with a review of legislative efforts to regulate genetic testing, and Dr. Critchfield's personal outlook in projecting genetic testing's roles ten years into the future.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Love Story: Lipid Education for Women’s Heart Health
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Navigating Myasthenia Gravis in Adolescents and Young Adults
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?